Alex Du, General Manager of the APAC Business Unit at Sirio Pharma Co., Ltd, In Asia, one of the primary challenges is the regulatory complexities across different regions. The rules governing nutraceuticals are not well defined in some areas, making compliance and market entry difficult. Quality control is another potential[Read More…]
Tag: CDMO
Sirio sees surging revenues driven by rapidly rising international sales
Overall turnover has risen to $508m [€469m] during 2023 – up 42.87 per cent year-on-year Sirio Pharma (SIRIO) the global nutraceutical contract development and manufacturing organisation (CDMO) announces record revenues at Vitafoods Europe with international sales reaching near parity with domestic revenues for the first time. The CDMO, which is among the largest[Read More…]
ScaleUp Bio announces initial customers from USA, Australia and Asia
New customers underscore significant interest in ScaleUp Bio’s unique CDMO value proposition to the global food tech industry ScaleUp Bio, a pioneering, Singapore-based, CDMO provider of submerged microbial precision fermentation facilities, expertise and services announced an initial list of customers, underscoring strong global interest in the company’s unique value proposition:[Read More…]
